Abstract
This paper summarizes the place of psychotherapy and psychoanalysis in the US health care system. It addresses trends in the field, tensions between biomedical and biopsychosocial models of mental and substance use disorders, and summarizes top-down legislative and bottom-up judicial actions that impact access to psychosocial treatments for mental and substance use disorders.